(Q35207775)

7 August 2017

1 reference

title

Regulation of testicular function in men: implications for male hormonal contraceptive development (English)

1 reference

7 August 2017

John K Amory

1

1 reference

7 August 2017

William J Bremner

series ordinal

2

1 reference

7 August 2017

publication date

1 June 2003

1 reference

The Journal of Steroid Biochemistry and Molecular Biology

7 August 2017

published in

1 reference

7 August 2017

volume

85

1 reference

7 August 2017

issue

2-5

1 reference

7 August 2017

page(s)

357-361

1 reference

The temporal relationship between gonadotropin releasing hormone (GnRH) and luteinizing hormone (LH) secretion in ovariectomized ewes.

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

Modulation of pulsatile gonadotropin secretion by testosterone in man

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

Testosterone administration inhibits gonadotropin secretion by an effect directly on the human pituitary

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

Differential sex steroid negative feedback regulation of pulsatile follicle-stimulating hormone secretion in healthy older men: deconvolution analysis and steady-state sex-steroid hormone infusions in frequently sampled healthy older individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

Inhibin-B: a likely candidate for the physiologically important form of inhibin in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

Stimulation of sperm production by human luteinizing hormone in gonadotropin-suppressed normal men

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

Chronic human chorionic gonadotropin administration in normal men: evidence that follicle-stimulating hormone is necessary for the maintenance of quantitatively normal spermatogenesis in man

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

Hypogonadism Caused by a Single Amino Acid Substitution in the β Subunit of Luteinizing Hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

Male hypogonadism due to a mutation in the gene for the beta-subunit of follicle-stimulating hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

Brief report: testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spermatogenesis in a hypophysectomized man.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

Would women trust their partners to use a male pill?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

Potential impact of hormonal male contraception: cross-cultural implications for development of novel preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

Repeated intramuscular injections of testosterone undecanoate for substitution therapy in hypogonadal men.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

An effective hormonal male contraceptive using testosterone undecanoate with oral or injectable norethisterone preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

Prospects for new hormonal male contraceptives.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libido

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

Oral progestogen combined with testosterone as a potential male contraceptive: additive effects between desogestrel and testosterone enanthate in suppression of spermatogenesis, pituitary-testicular axis, and lipid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

Desogestrel plus testosterone effectively suppresses spermatogenesis but also causes modest weight gain and high-density lipoprotein suppression.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

Low dose of cyproterone acetate and testosterone enanthate for contraception in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

An oral regimen of cyproterone acetate and testosterone undecanoate for spermatogenic suppression in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

Clinical Trial of Transdermal Testosterone and Oral Levonorgestrel for Male Contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

A novel male contraceptive pill-patch combination: oral desogestrel and transdermal testosterone in the suppression of spermatogenesis in normal men.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

Combination of subcutaneous levonorgestrel implants and transdermal dihydrotestosterone gel for male hormonal contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

Daily testosterone and gonadotropin levels are similar in azoospermic and nonazoospermic normal men administered weekly testosterone: implications for male contraceptive development

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

Efficacy and acceptability of testosterone implants, alone or in combination with a 5alpha-reductase inhibitor, for male hormonal contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

Effects of testosterone plus medroxyprogesterone acetate on semen quality, reproductive hormones, and germ cell populations in normal young men.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

Sensitive LH and FSH assays for monitoring low serum levels in men undergoing steroidal contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

Oestradiol enhances testosterone-induced suppression of human spermatogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

Differential regulation of gonadotropin secretion by testosterone in the human male: absence of a negative feedback effect of testosterone on follicle-stimulating hormone secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900205-X

7 January 2021

10.1016/S0960-0760(03)00205-X

Identifiers

DOI

1 reference

7 August 2017

1 reference